Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Common Equity: 2011-2025

Historic Common Equity for Mesa Laboratories (MLAB) over the last 15 years, with Sep 2025 value amounting to $178.5 million.

  • Mesa Laboratories' Common Equity rose 10.54% to $178.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $178.5 million, marking a year-over-year increase of 10.54%. This contributed to the annual value of $159.8 million for FY2025, which is 9.93% up from last year.
  • Per Mesa Laboratories' latest filing, its Common Equity stood at $178.5 million for Q3 2025, which was up 3.46% from $172.5 million recorded in Q2 2025.
  • Mesa Laboratories' Common Equity's 5-year high stood at $406.2 million during Q1 2021, with a 5-year trough of $145.4 million in Q1 2024.
  • Moreover, its 3-year median value for Common Equity was $172.5 million (2025), whereas its average is $245.5 million.
  • As far as peak fluctuations go, Mesa Laboratories' Common Equity spiked by 84.64% in 2021, and later crashed by 63.05% in 2024.
  • Quarterly analysis of 5 years shows Mesa Laboratories' Common Equity stood at $396.3 million in 2021, then dropped by 2.30% to $387.2 million in 2022, then increased by 4.07% to $403.0 million in 2023, then slumped by 60.34% to $159.8 million in 2024, then rose by 10.54% to $178.5 million in 2025.
  • Its Common Equity stands at $178.5 million for Q3 2025, versus $172.5 million for Q2 2025 and $159.8 million for Q1 2025.